3/27
06:06 pm
envb
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025 [Yahoo! Finance]
Medium
Report
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025 [Yahoo! Finance]
3/27
05:40 pm
envb
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025
Medium
Report
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025
3/18
08:56 am
envb
Enveric Biosciences Announces Registration of Five Trademarks [Yahoo! Finance]
Low
Report
Enveric Biosciences Announces Registration of Five Trademarks [Yahoo! Finance]
3/18
08:00 am
envb
Enveric Biosciences Announces Registration of Five Trademarks
Low
Report
Enveric Biosciences Announces Registration of Five Trademarks
2/25
08:00 am
envb
Enveric Biosciences Announces Withdrawal of Petition Against Its Patent
Medium
Report
Enveric Biosciences Announces Withdrawal of Petition Against Its Patent
2/20
08:13 am
envb
Enveric Biosciences reports EB-003 receptor engagement assay data [Yahoo! Finance]
Medium
Report
Enveric Biosciences reports EB-003 receptor engagement assay data [Yahoo! Finance]
2/19
08:00 am
envb
Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data
Medium
Report
Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data
1/29
08:00 am
envb
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option
High
Report
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option
1/28
05:00 pm
envb
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
High
Report
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
1/28
08:00 am
envb
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
High
Report
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
1/22
07:02 pm
envb
Kaida BioPharma Appoints Co-Founder Dr. Stella K. Vnook as Chairperson of the Board [Yahoo! Finance]
Low
Report
Kaida BioPharma Appoints Co-Founder Dr. Stella K. Vnook as Chairperson of the Board [Yahoo! Finance]
12/30
08:12 am
envb
Enveric Biosciences announces issuance of U.S. patent [Yahoo! Finance]
Medium
Report
Enveric Biosciences announces issuance of U.S. patent [Yahoo! Finance]
12/29
08:00 am
envb
Enveric Biosciences Announces Patent Issuance
Medium
Report
Enveric Biosciences Announces Patent Issuance